Idorsia
Irinel Andreea Coserea is a seasoned professional in regulatory affairs and project leadership, currently serving as Director and Global Regulatory Project Leader at Idorsia Pharmaceuticals Ltd since January 2021. Previous roles include Associate Director of EU Regulatory Affairs at Mirum Pharmaceuticals and various positions at Santhera Pharmaceuticals, culminating in the role of Senior Regulatory Affairs Manager. Early experience includes roles in scientific research as a Postdoctoral Researcher at Abbott GmbH & Co. KG and as a Scientist at 3-V Biosciences. Irinel Andreea Coserea holds a PhD in Neurobiology from Heidelberg University and a Master's degree in Molecular Biology from the University of Bucharest.
This person is not in any teams
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.